出 版 商：
GBI Research
排序：
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs
2014/06/01
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted DrugsSumma.. more USD 3,500
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries
2014/06/01
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent ExpiriesS.. more USD 3,500
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany
2014/06/01
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Appro.. more USD 3,500
Market Snapshot: Glucose Monitoring Devices 2006 to 2020 - Southeast Asia (Taiwan, Indonesia, Malaysia, Singapore, Vietnam)
2014/05/31
Market Digest: Glucose Monitoring Devices 2006 to 2020 - Southeast Asia (Taiwan, Indonesia, Malaysia, Singapore, Vietnam)
Summary
GBI Research’s rep.. more USD 1,750
Market Snapshot: Glucose Monitoring Devices 2014 - Southeast Asia (Taiwan, Indonesia, Malaysia, Singapore, Vietnam)
2014/05/30
Market Snapshot: Glucose Monitoring Devices 2014 - Southeast Asia (Taiwan, Indonesia, Malaysia, Singapore, Vietnam)SummaryGBI Research’s report, “Mark.. more USD 1,750
Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets
2014/05/30
Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing MarketsSummaryGBI Rese.. more USD 3,500
Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation
2014/05/30
Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class InnovationSummaryGBI Research has released the pharma report: “Frontier Ph.. more USD 3,500
Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies
2014/05/12
Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapi.. more USD 3,500
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options
2014/05/12
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment OptionsSummaryGBI Research, .. more USD 3,500
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
2014/04/14
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Im.. more USD 3,500